文献速递免疫规划妇幼与学校卫生

青少年人乳头瘤病毒疫苗接种的家长报告与提供者报告比较

A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents.
PubMed 文献 · Am J Prev Med · 2016-11-24

该研究基于2014年美国全国青少年免疫调查中20,827名青少年的数据,于2016年分析,比较家长回忆与提供者电子病历报告的人乳头瘤病毒(HPV)疫苗接种状态。结果显示,启动接种率家长报告为51.3%、提供者报告为50.0%,完成接种率分别为30.7%和27.3%;家长报告启动接种的敏感度86.0%、特异度87.4%、κ系数0.73,完成接种的敏感度71.5%、特异度91.1%、κ系数0.64。结论认为家长回忆在监测HPV疫苗启动接种方面与提供者报告可比,但在完成接种方面可比性较低。

要点

  • 家长报告与提供者报告的HPV疫苗启动接种率接近(51.3% vs 50.0%)。
  • 家长报告启动接种的κ系数为0.73,完成接种的κ系数为0.64。
  • 家长回忆在监测启动接种方面与提供者报告可比,完成接种可比性较低。

核心结论

  • 家长回忆在监测青少年HPV疫苗启动接种方面与提供者报告可比,但在完成接种方面可比性较低。

研究设计与样本

  • 分析2014年美国全国青少年免疫调查中20,827名青少年的数据,于2016年进行,比较家长回忆与提供者电子病历报告的HPV疫苗接种状态。

主要发现

  • HPV疫苗启动接种率家长报告为51.3%,提供者报告为50.0%;完成接种率家长报告为30.7%,提供者报告为27.3%。
  • 以提供者报告为参照,家长报告启动接种的敏感度86.0%、特异度87.4%、阳性预测值87.5%、阴性预测值85.9%、κ系数0.73。
  • 以提供者报告为参照,家长报告完成接种的敏感度71.5%、特异度91.1%、阳性预测值78.5%、阴性预测值87.6%、κ系数0.64。
  • 与HPV疫苗接种相关的特征(青少年年龄、性别、就诊次数和地区)在家长报告与提供者报告间相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: There is considerable effort at the state and national levels to monitor human papillomavirus (HPV) vaccine uptake and understand the factors that influence who gets vaccinated. Accurate measurement of vaccination coverage is critical for monitoring HPV vaccination. This study aimed to determine comparability between parent- and provider-reported HPV vaccination status for a sample of adolescents in the U.S. METHODS: Data from the 2014 National Immunization Survey-Teen were analyzed in 2016 for 20,827 adolescents. Information on HPV vaccine uptake (initiation [one or more dose] and completion [three or more doses]) was obtained using parental (recall) and provider reports (electronic medical records). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and κ-coefficient were computed to determine how comparable parental and provider (ref group) reports were for HPV vaccination. RESULTS: Prevalence of HPV vaccine initiation was comparable between parental and provider report (51.3% vs 50.0%) and for completion (30.7% vs 27.3%). Compared with provider report, parent-reported HPV vaccine initiation had high sensitivity (86.0%), specificity (87.4%), PPV (87.5%), NPV (85.9%), and acceptable κ-coefficient (0.73). Compared with provider report, parent-reported HPV vaccine completion had a sensitivity of 71.5%, specificity of 91.1%, PPV of 78.5%, NPV of 87.6%, and κ-coefficient of 0.64. Similar characteristics-adolescent age, sex, number of doctor visits, and region-were associated with HPV vaccine uptake using parental and provider reports. CONCLUSIONS: Parental recall is comparable to provider report in monitoring HPV vaccine uptake for adolescents, although parental recall is less comparable for HPV vaccine completion.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Adjei Boakye E, Tobo BB, Osazuwa-Peters N, et al. A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents. Am J Prev Med. 2016. PMID: 27890518. doi:10.1016/j.amepre.2016.10.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。